Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypertension, Essential”

736 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 736 results

Large-scale testing (Phase 3)Study completedNCT01556997
What this trial is testing

Perindopril Amlodipine for the Treatment of Hypertension

Who this might be right for
Essential Hypertension
Symplmed Pharmaceuticals LLC 837
Large-scale testing (Phase 3)Study completedNCT02269176
What this trial is testing

Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 330
Not applicableStudy completedNCT01195805
What this trial is testing

The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables

Who this might be right for
Essential Hypertension
Regional Hospital Holstebro 25
Not applicableUnknownNCT02018497
What this trial is testing

Essential Hypotension and Allostasis Registry

Who this might be right for
Blood PressureDepressionPanic Attack+16 more
CES University 5,000
Post-approval studies (Phase 4)Study completedNCT00858702
What this trial is testing

Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension

Who this might be right for
Hypertension
Daiichi Sankyo Co., Ltd. 105
Not applicableStudy completedNCT04944472
What this trial is testing

Possibilities of Perceiving Information on the Primary Prevention of Cardiovascular Diseases in Persons Suffering From Essential Hypertension Through a Social Network

Who this might be right for
Prevention, Arterial Hypertension
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department 125
Post-approval studies (Phase 4)Study completedNCT00654875
What this trial is testing

Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension.

Who this might be right for
Essential Hypertension
Novartis 328
Post-approval studies (Phase 4)Study completedNCT00687973
What this trial is testing

Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg

Who this might be right for
Hypertension
Novartis Pharmaceuticals 393
Very early researchStudy completedNCT04423627
What this trial is testing

Sympathetic Regulation of Large Artery Stiffness in Humans With ISH

Who this might be right for
Hypertension, SystolicStiffness, Aortic
University of Iowa 100
Not applicableUnknownNCT01742702
What this trial is testing

HaemoDYNAMICs in Primary and Secondary Hypertension

Who this might be right for
Primary HypertensionSecondary HypertensionAortic Stenosis+1 more
Tampere University 2,000
Large-scale testing (Phase 3)Study completedNCT00254475
What this trial is testing

Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia

Who this might be right for
Essential HypertensionHypercholesterolemia
Novartis 871
Not applicableStudy completedNCT05836181
What this trial is testing

The Effect of Eye Movement Desensitization and Reprocessing Intervention in Hypertension Patient.

Who this might be right for
Eye Movement Desensitization and Reprocessing InterventionBlood PressureHeart Rate Variability+1 more
Miao-Yi Chen 110
Not applicableUnknownNCT02244177
What this trial is testing

Relationship of Essential Hypertension and Its Treatments on the Postoperative Pain Management: a Prospective, Observational, Cross-sectional Study

Who this might be right for
Hypertension
Kaohsiung Veterans General Hospital. 300
Early research (Phase 1)Not Yet RecruitingNCT07486453
What this trial is testing

Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets

Who this might be right for
Primary Hypertension
Shenzhen Salubris Pharmaceuticals Co., Ltd. 60
Large-scale testing (Phase 3)WithdrawnNCT01865188
What this trial is testing

Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension

Who this might be right for
Hypertension
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02822222
What this trial is testing

Safety Study of RMJH-111b to Treat Essential Hypertension

Who this might be right for
Essential Hypertension
RMJ Holdings, LLC 22
Not applicableStudy completedNCT03855605
What this trial is testing

Diagnosis of Hypertension by Home Blood Pressure Monitoring

Who this might be right for
Hypertension,EssentialHome Blood PressureAmbulatory Blood Pressure
DongGuk University 470
Testing effectiveness (Phase 2)Study completedNCT03897868
What this trial is testing

Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension

Who this might be right for
Hypertension
Hanmi Pharmaceutical Company Limited 248
Large-scale testing (Phase 3)Looking for participantsNCT06643819
What this trial is testing

Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A

Who this might be right for
Essential Hypertension
Chong Kun Dang Pharmaceutical 324
Early research (Phase 1)Study completedNCT00937534
What this trial is testing

Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 22
Load More Results